Industry resources and insights

Sort by year
  • All time
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020 and older
Articles
06.07.2026
Why Pricing Strategy Must Start Earlier: Linking E...

Pricing strategy is often treated as a launch activity. However, by the time teams begin detailed pr...

Read more
Webinar
01.07.2026
Dissecting the First EU Joint Clinical Assessment ...

The first EU Joint Clinical Assessment (JCA) has now been published, providing the first practical i...

Read more
Articles
22.06.2026
Mid-Year Trends Refresh of 2026 Predicted Pharma P...

At the start of 2026, we identified five key pharmaceutical pricing and market access trends expecte...

Read more
Poster
10.06.2026
A comparison of conflict-of-interest (CoI) managem...

Expert contributions are critical to health technology assessment (HTA), particularly in rare diseas...

Read more
Insider Insights
09.06.2026
Spain HTA reform 2026: Will Your Evidence Measure ...

Spain has published Royal Decree 415/2026[1], setting out a new national framework for health techno...

Read more
Insider Insights
20.05.2026
Orphan medicines in the EU: Key EU General Pharma ...

EU GPL: A Shift Towards More Selective Incentives for Orphan Drug Manufacturers In March 2026, the ...

Read more
Load more
Browse by topic
Content type
  • All
  • Articles
  • Case Studies
  • Checklist
  • Guide
  • Insider Insights
  • News
  • Poster
  • Publications
  • Webinar
Subscribe
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Consent

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch